What is Myriad Genetics's current ratio?

Myriad Genetics (MYGN) reported current ratio of 2.4× in Q1 2026.

How has Myriad Genetics's current ratio changed year-over-year?

Myriad Genetics's current ratio increased by 26.4% year-over-year, from 1.9× to 2.4×.

What is the long-term trend for Myriad Genetics's current ratio?

Over 5 years (2020 to 2025), Myriad Genetics's current ratio has grown at a -1.4% compound annual growth rate (CAGR), from 2.7× to 2.5×.

What does current ratio mean?

Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

Myriad Genetics MYGN Current ratio

Current ratio at other companies

Labcorp HoldingsLH

1.7×-0.1×

Quest DiagnosticsDGX

1.2×-0.3×

NeoGenomicsNEO

4.4×+2.4×

VeracyteVCYT

9.3×+4.2×

Guardant HealthGH

4.7×+0.6×

Natera, Inc.NTRA

3×-0.9×

Other financials

Income statement

See full

Revenue$200.4M+2.3%

Gross profit$137.6M+2.5%

Operating income-$30.7M-5.9%

Net income-$34.1M-34,000%

EPS (diluted)-$0.36—

Balance sheet

See full

Cash & equivalents$126.0M+24.8%

Total debt$211.5M+34.2%

Total equity$337.4M-52.1%

Total assets$673.7M-33.0%

Cash flow

See full

Operating cash flow-$15.7M+3.7%

CapEx$18.8M+181%

Free cash flow-$19.7M+65.1%

Valuation

See full

Market cap$512.85M+13.1%

Enterprise value$598.35M+17.3%

P/S0.6×+0.1×

Profitability

See full

Gross margin70%0.0pp

Operating margin-46.9%-88.3pp

Net margin-48.2%-72.9pp

FCF margin-17%—

Returns & leverage

See full

Return on equity-76.7%-98.4pp

Debt / equity0.6×+0.4×

Where this comes from

Calculated from Myriad Genetics’s reported figures.

total current assets/total current liabilities=2.4×

Based on the most recent quarter.

The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Myriad Genetics's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Myriad Genetics's current ratio?: Myriad Genetics (MYGN) reported current ratio of 2.4× in Q1 2026.
How has Myriad Genetics's current ratio changed year-over-year?: Myriad Genetics's current ratio increased by 26.4% year-over-year, from 1.9× to 2.4×.
What is the long-term trend for Myriad Genetics's current ratio?: Over 5 years (2020 to 2025), Myriad Genetics's current ratio has grown at a -1.4% compound annual growth rate (CAGR), from 2.7× to 2.5×.
What does current ratio mean?: Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.